Inclusion Criteria:  Cancer patients receiving active therapy (chemotherapy, immunotherapy, target therapy, radiotherapy) Cancer patients receiving hormonal therapy for metastatic disease. Must be ≥18 years of age. Written, signed consent for study participation.  Exclusion Criteria:  Cancer patients receiving hormonal therapy in adjuvant regimen. Patients in follow-up and who have completed their cancer treatment for > 6 months. Life expectancy less than 3 months.